| Colorectal cancer study raises questions on screening
frequency
Wednesday, July 02, 2003
By Anita Srikameswaran, Post-Gazette Staff Writer
A large national study led by local researchers indicates that
screening for colorectal cancer every three years instead of the
recommended five years can uncover a small number of cancers that
might otherwise have gone undetected -- and untreated -- for another
two years.
But the results are not enough to prompt a change in screening
guidelines, which recommend flexible sigmoidoscopy every five years
for people 50 and older. In the procedure, the lower portion of the
large intestine is examined with a flexible, fiber optic scope.
Of more than 9,000 study participants, six were found to have a
cancer and 72 to have an advanced, precancerous lesion three years
after their first sigmoidoscopy. The findings were published today
in the Journal of the American Medical Association.
Although there weren't many new cancers detected, the study
raises questions about how frequently screening exams, including a
more extensive exam called a colonoscopy, should be done, said lead
investigator Dr. Robert Schoen, a gastroenterologist at the
University of Pittsburgh School of Medicine.
"It's not a large number of cancers, on the one hand," he said.
"On the other hand, it does show that the more frequently one tests,
one will find things that are potentially of importance."
The study is by the Prostate, Lung, Colorectal and Ovarian Cancer
Screening Trial Group, a federally funded research project that has
recruited more than 154,000 people from 10 medical centers to see
whether various screening tests reduce the number of deaths from
those cancers.
For the colorectal cancer study, 9,317 people who had a
sigmoidoscopy and had no sign of cancer or precancer underwent the
same procedure three years later.
Almost 14 percent, or 1,292 patients, had an abnormal follow-up
exam, meaning a polyp or mass was detected. Of those, 847 then had a
colonoscopy, in which the entire large intestine was examined with a
scope, and 104 had another sigmoidoscopy. In the re-examined group,
72, or 25 percent, had an advanced precancerous polyp and 6, or 0.6
percent, had cancer in the sigmoid colon.
It's not known whether the suspicious polyps might have been
present during the first examination, Schoen said.
"There's no way to know whether it was missed or whether it grew
[later]," he said. But 80 percent had advanced precancerous lesions
in a portion of the colon that was "adequately examined at the
initial sigmoidoscopy," the researchers said.
Many experts contend that colonoscopy, which is recommended every
10 years after age 50, is the better screening test because it can
be done less often and the entire colon is examined. Studies
indicate that 1 to 2 percent of people will have an advanced polyp
or cancer detected by colonoscopy that would not be found with
sigmoidoscopy, the researchers said.
Schoen said that in light of the new findings, a 10-year interval
between colonoscopies may be too long. So far, no one has completed
a study that looked at the number of dangerous lesions that might be
found if colonoscopies were done more frequently.
It might be necessary to do sigmoidoscopy or other screening
tests between colonoscopies, Schoen said. Better yet, blood tests
that can detect problems need to be developed.
For now, "I don't think we should change the recommendation from
five years to three years," he said. "We need to watch this very
carefully and we need more studies."
Dr. Robert Fletcher, of Harvard Medical School, came to the same
conclusion.
"All screening tests, sigmoidoscopy included, are imperfect," he
wrote in a commentary also published today. "Screening tests are
chosen because they are easier, safer and less expensive than
definitive tests, but at the cost of missing some cancers and
sounding many false alarms."
Fletcher noted that it's not known whether finding the advanced
precancerous polyps will prevent colorectal cancer deaths, the main
goal of the trial, "because it is not known how often [they]
progress to symptomatic, incurable cancers."
Schoen said that another arm of the study is examining a group of
people who had sigmoidoscopies five years apart.
Anita Srikameswaran can be reached at
anitas@post-gazette.com
or 412-263-3858.
|